BioTuesdays
Zenabis Logo

Zenabis names Shai Altman as president and CEO

Zenabis Global (TSX:ZENA) appointed Shai Altman as president and CEO, effective September 1.  Mr. Altman will replace interim CEO, Kevin Coft, who will return to his role as Zenabis’ chief facilities officer. Mr. Altman...

Chimerix appoints Allen Melemed as CMO

Chimerix (NASDAQ:CMRX) appointed Dr. Allen Melemed as its CMO. Dr. Melemed was most recently a distinguished medical fellow and senior director of North American regulatory affairs oncology at Eli Lilly (NYSE:LLY). He...

Akcea names Damien Devitt as CEO

Damien Devitt, who has been interim CEO of Akcea Therapeutics (NASDAQ:AKCA) since September 2019, has been promoted to CEO, effective immediately, and will continue to serve as a member of Akcea’s board. “With his...

Covetrus names Benjamin Wolin as CEO

Benjamin Wolin, who has been acting CEO of Covetrus (NASDAQ:CVET) since October 2019, has been promoted to president and CEO, effective immediately. Covetrus was formed in February 2019 as the result of a spin out of...

Sign up for the BioTuesdays weekly newsletter

Get the latest news on the healthcare industry’s corporate and clinical developments, executive moves, and market updates. Every Tuesday, in your inbox.